Neumann J, Hofmann B, Gergs U (2024b) Positive inotropic effects of glucose-dependent insulinotropic polypeptide in the human atrium
This research ultimately led to the development of the first GLP-1 receptor agonist approved for diabetes treatment
Alternative treatment of restless legs syndrome: an overview of the evidence for mind-body interventions, lifestyle interventions, and neutraceuticals
It is temporary, and hair regrows once weight stabilizes
Last reviewed: June 25, 2026 Last updated: June 25, 2026 Written by: Jay Hastings, CEO of PlexusDx Jay Hastings is the CEO of PlexusDx, a precision health company focused on genetic testing, blood biomarker insights, and personalized wellness recommendations